Announcing our newest Management member

Karen Tornøe joined Cytovac the 1st of April 2019 as Chief Medical Officer.

Karen holds a MD and Ph.D. degree from the University of Copenhagen. She has a broad clinical experience as MD and a long experience within clinical drug development and regulatory strategies from employments at the Danish Medicines Agency and Novo Nordisk.

Karen will be our medical specialist and have the over-all responsibility of our clinical development.

We look very much forward to working together with Karen as we expand our pipeline with Triple Negative Breast Cancer in 2019.